Bovie Medical Corporation (“Bovie” or the “Company”) (NYSE Amex: BVX), a manufacturer and marketer of electrosurgical products, today announced that it received a patent for a laparoscopic electrosurgical electrical leakage detection device. The device, when developed, will continuously monitor electrosurgical current from the generator, and is designed to prevent burns to the patient by detecting leakage of electrical current in the surgical handpiece during monopolar electrosurgery. The device will shut down the system if leakage is detected; thus, reducing burn risks to the patient. Without an electrosurgical safety device, capacitive coupling and insulation failure are two unwanted side effects that can result in patient injury since these injuries often happen outside the view of the video camera during a laparoscopic procedure. These unintended injuries can result in additional surgical procedures being performed on the patient. After completing the development of the device, the Company will file a 510k application with the FDA for clearance to market. The Company anticipates incorporating the device into electrosurgical generators manufactured by Bovie and others. Cautionary Note on Forward-Looking Statements Certain matters discussed in this news release and oral statements made from time to time by representatives of the Company may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and the Federal securities laws. Although the Company believes that the expectations reflected in such forward-looking statements are based upon reasonable assumptions, it can give no assurance that its expectations will be achieved. Forward-looking information is subject to certain risks, trends and uncertainties that could cause actual results to differ materially from those projected. Many of these factors are beyond the Company’s ability to control or predict. Important factors that may cause actual results to differ materially and that could impact the Company and the statements contained in this news release can be found in the Company’s filings with the Securities and Exchange Commission including the Company’s Report on Form 10-K for the year ended December 31, 2010. For forward-looking statements in this new release, the Company claims the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. The Company assumes no obligation to update or supplement any forward-looking statements whether as a result of new information, future events or otherwise.
For further information about the Company’s current and new products, please refer to the Investor Relations section of Bovie’s website www.boviemedical.com.